The Perspectives in the Management for Warfarin m Resistance and Toxicity Associated with Vitamin K Epoxide Reductase Dysfunction - Juniper Publishers
JUNIPER PUBLISHERS- OPEN ACCESS JOURNAL OF TOXICOLOGY
The Perspectives in the Management for Warfarin m Resistance and Toxicity Associated with Vitamin K Epoxide Reductase Dysfunction
Authored by Ahmed Abdul-Sabour Bader
Anticoagulant
therapy is being increasingly used the treatment and prevention of
thromboembolic events, and warfarin remains the most frequently used agent for
longterm anticoagulation in all patient groups. Warfarin, one of oral
anticoagulant drugs that exerting its anticoagulant effect by inhibiting the
enzyme vitamin K epoxide reductase (VKORC1), thereby preventing vitamin K
recycling and vitamin K-dependent carboxylation of the coagulation factors II,
VII, IX, and X; where the carboxylation is very critical for biosynthesis of
these blood clotting factors leading to a marked decrease in blood coagulation
process. Anticoagulation response to a fixed dose of warfarin is notoriously
difficult to predict because of interindividual variability in dose
requirement. This, together with the drug’s narrow therapeutic window,
necessitates maintenance of anticoagulation status within a tight therapeutic
range facilitated by frequent international normalized ratio (INR) monitoring
to ensure the efficacy and safety of therapy.
Warfarin
resistance may develop as a result of noncompliance, exogenous consumption of
vitamin K, and concurrent ingestion of other agents known to decrease
warfarin’s effects. Unfortunately, an increasing number of genetic variations
of enzyme vitamin K epoxide reductase affecting warfarin pharmacodynamics
and/or pharmacokinetics were found to have a major impact on the warfarin dose
in adults that had been found to produce detrimental harmful effects on body
due to either over coagulation or under coagulation (resistance) to its
therapeutic action. These genetic variations are found in single nucleotide
polymorphisms (SNPs) in VKORC1 that leading to loss of VKORC1 sensitivity to
warfarin; making it difficult or impossible to adequately lower vitamin K
levels.
For more Open Access Journals in Juniper Publishers please
click on: https://juniperpublishers.com
For more articles in Open Access Journal of
Toxicology please click on: https://juniperpublishers.com/oajt/
To know more about Peer Review Journal of Toxicology
To read more… Full text
please click on: https://juniperpublishers.com/oajt/OAJT.MS.ID.555565.php
Comments
Post a Comment